Flat Glass Coatings Market Size Worth Around $5.12 billion by 2026: Acumen Research and Consulting
/
Date21 Feb 2019
Email Print Friendly Share LOS ANGELES, Feb. 20, 2019 (GLOBE NEWSWIRE) — The global Flat glass coatings market size is anticipated to around USD 5.12... Read More →
Flow Capital Disposes of Ownership of Lattice Biologics Ltd. Common Shares
/
Date21 Feb 2019
Email Print Friendly Share TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) — Flow Capital Corp. (“Flow”) (TSXV: FW) announces that it has filed an early warning report... Read More →
Armstrong World Industries Declares Cash Dividend for First Quarter 2019
/
Date21 Feb 2019
Email Print Friendly Share LANCASTER, Pa., Feb. 20, 2019 (GLOBE NEWSWIRE) — Armstrong World Industries, Inc. (NYSE:AWI), a leader in the design, innovation and manufacture of... Read More →
Maui Land & Pineapple Reports 2018 Net Income of $0.6 Million
/
Date21 Feb 2019
Email Print Friendly Share KAPALUA RESORT, Hawaii, Feb. 20, 2019 (GLOBE NEWSWIRE) — Maui Land & Pineapple Company, Inc. (NYSE: MLP) reported net income of... Read More →
LOCINDUS : Franchissement de seuils légal et statutaire
/
Date21 Feb 2019
Email Print Friendly Share Paris, le 21 février 2019 FRANCHISSEMENT DE SEUILS LEGAL ET STATUTAIRE Par courrier en date du 21 février... Read More →
TREB Market Year in Review & Outlook 2019 Economic Summit – York Region
/
Date21 Feb 2019
Email Print Friendly Share TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) — Media are invited to attend an exclusive York Region market year in review and... Read More →
Veðskuldabréfasjóðurinn Virðing: Ársreikningur vegna ársins 2018
/
Date21 Feb 2019
Email Print Friendly Share Veðskuldabréfasjóðurinn Virðing, fagfjárfestasjóður í rekstri Júpíter rekstrarfélags hf., birtir ársreikning sinn fyrir árið 2018. Hagnaður sjóðsins á árinu 2018 nam 53.328... Read More →
Immunomedics Announces Publication of Triple-Negative Breast Cancer Data With Sacituzumab Govitecan in the New England Journal of Medicine
/
Date21 Feb 2019
Email Print Friendly Share MORRIS PLAINS, N.J., Feb. 20, 2019 (GLOBE NEWSWIRE) — Immunomedics, Inc., (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company... Read More →
Hoth Therapeutics Inc. Announces Closing of Initial Public Offering
/
Date21 Feb 2019
Email Print Friendly Share NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) — Hoth Therapeutics Inc. (NASDAQ: HOTH), a development stage biopharmaceutical company focused on unique... Read More →